Nuclear factor-κB is upregulated in colorectal cancer

Surgery

Volumn 130, Issue 2, 2001, Pages 363-369

  Lind, D Scott ^a   Hochwald, Steven N ^a   Malaty, John ^a   Rekkas, Stelio ^a   Hebig, Paul ^a   Mishra, Girish ^a   Moldawer, Lyle L ^a   Copeland, Edward M ^a   MacKay, Sally ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BROMINE DERIVATIVE; CASPASE 3; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; THYMIDINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL KILLING; CELL VIABILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR UPREGULATION;

EID: 0034896686     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.116672     Document Type: Article

References (30)

1. Cancer statistics 2000
2. Apoptosis in cancer: Therapeutic implications
3. Caspases: The proteases of the apoptotic pathway
4. Signal transduction through NF-κB
5. NF-κB to the rescue: RELS, apoptosis and cellular transformation
6. How NF-κB is activated: The role of the I-κB kinase (IKK) complex
7. The transcription factor NF-κB: Control of oncogenesis and cancer therapy resistance
8. Aberrant NF-κB/Rel expression and the pathogenesis of breast cancer
9. Constitutive activation of NF-κB in primary adult leukemia cells
10. Constitutive activation of KF-kappaB during progression of breast cancer to hormone-independent growth
11. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells
12. A rapid and sensitive method for the quantification of microgram amounts of protein utilizing the principle of protein dye binding
13. Caspase-3-dependent organ apoptosis early after bum injury
14. Gemcitabine: Metabolism, mechanisms of action, and self-potentiation
15. Introduction: Gemcitabine - Status of preclinical studies and perspectives for future clinical applications of this novel nucleoside analog
16. Activation of NF-κB by antineoplastic agents: Role of protein kinase C
17. Nuclear factor-κB/IκB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells
18. Inhibition of NF-κB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis
19. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-camptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation
20. Stable inhibition of nuclear factor-kappa B in cancer cells does not increase sensitivity to cytotoxic drugs
21. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
22. Expression of a dominant-negative mutant inhibitor of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo
23. Inhibition of nuclear factor-κB activation attentuates apoptosis resistance in lymphoid cells
24. Regulation of NF-κB activity by I-κB-related proteins in adenocarcinoma cells
25. The role of NK-κB/IκB proteins in cancer: Implications for novel treatment strategies
26. Proteasome-dependent regulation of p21 expression
27. NK-κB-mediated induction of MDRLB expression by insulin in rat hepatoma cells
28. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T-lymphocytes via the activation of NK-κB and AP-1
29. Transcriptional cross-talk between NF-κB and p53
30. NF-κB anti-apoptosis: Induction of TRAF1 and TRAF2 and c-IAPI and c-IAP2 to suppress caspase 8 activation